PsychedelicNewsBreaks Archive - Page 53 of 68

TuesdayMar 09, 2021 1:17 pm

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters Strategic LOI with ShroomBloom

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, today announced that it signed a letter of intent (“LOI”) with ShroomBloom Labs/Floja Bioscience Inc. to enter into an agreement for the supply of psychedelic mushroom biomass. British Columbia-based ShroomBloom is a mushroom cultivator leveraging a unique growing method that uses a sustainable forest product to grow organic Psilocybe Azurescens, also known as Azures, one of the most potent psilocybin mushrooms ever found. Under the terms of the LOI, Pure Extracts would be granted “most…

MondayMar 08, 2021 10:37 am

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Commences Trading on the OTCQB(R) Venture Market

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its shares have commenced trading on the OTCQB(R) Venture Market under the symbol “CLXPF.” “With the commencement of trading on the OTCQB, Cybin has achieved another important milestone on its path to advancing mental health care through evidenced-based therapeutics. This additional capital markets exposure offers us greater visibility within the investment community, which should enhance our liquidity and increase our access to institutional and retail investors,” said Doug Drysdale, CEO of Cybin. “This support is extremely valuable to us as we continue to progress…

ThursdayMar 04, 2021 10:27 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Applies for Health Canada Dealer’s Licence

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, today announced that its wholly owned subsidiary, Pure Mushrooms Corp., has submitted an application to Health Canada for a Dealer’s Licence under the Controlled Drugs and Substances Act (“CDSA”). “We are grateful to have the support of one of Canada’s premiere consulting companies with subject matter proficiency in cannabis and other regulated consumer product industries in assisting that we submitted a fully compliant Dealer’s Licence application to Health Canada,” said Pure Extracts CEO Ben Nikolaevsky.…

WednesdayMar 03, 2021 10:15 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Subsidiary Orders 30,000-Plus Vape Cartridges, Pens for Retail Distribution

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, through its subsidiary Pure Extracts Manufacturing Corp., has ordered more than 30,000 vape cartridges and vape pens. Pure Extracts will fill the cartridges and pens, which are produced by a global manufacturer, with a variety of some of its proprietary, full-spectrum oil (“FSO”) formulations; the company has more than 30 of these exclusive oil formulations. Pure Extracts recently announced a retail distribution agreement, and this order is an indication that the company is preparing to…

ThursdayFeb 25, 2021 10:41 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces It Has Submitted Multiple SKUs to Health Canada for Approval

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, has submitted a Notice of New Cannabis Product (“NNCP”) application to Health Canada through its wholly owned subsidiary Pure Extracts Manufacturing Corp. The application requests Health Canada’s approval for more than 20 of Pure Extract’s retail cannabis products including cannabis extracts and edible cannabis such as THC and CBD vapes, and three flavors of gummies. Once approval is received, Pure Extracts anticipates offering the products under its Pure Pulls Vapes and Pure Chews Gummies branded…

TuesdayFeb 23, 2021 11:42 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Submits Sales License Application to Health Canada

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, announced that, through its wholly owned subsidiary Pure Extracts Manufacturing Corp., it has submitted an application to Health Canada to amend its current license to permit the sale of cannabis extract products. Pure Extracts plans to sell such extracts to provincially authorized distributors and retailers nationwide. This announcement comes on the heels of the company entering a distribution agreement with a large Canadian Licensed Producer to distribute Pure Extracts’ vape and edible products. The company…

FridayFeb 19, 2021 1:59 pm

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (OTC: CLXPF) to Leverage Breakthrough Tech to Measure Real-Time Brain Activity During Psychedelic Experiences

Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently announced its collaboration with neurotech pioneer HI LLC dba Kernel. According to the update, CYBN will leverage Kernel Flow, Kernel’s breakthrough technology, for its upcoming clinical work to quantify brain activity in real time during psychedelic experiences. “Access to Kernel’s innovative Flow technology adds another exciting dimension to the investigative work that Cybin is doing to develop breakthrough treatments for mental health disorders such as depression and addiction,” said Cybin CEO Doug Drysdale in a recent update. “Currently, clinical investigators rely…

ThursdayFeb 18, 2021 10:16 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Signs Distribution Agreement with Canada House Wellness Group

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company specializing in cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, has signed an agreement with Canada House Wellness Group (CSE: CHV) to distribute concentrate products through existing provincial distribution channels. Canada House Wellness is a fully integrated medical cannabis company. The two companies have entered into a Cannabis 2.0 distribution agreement. The agreement notes that Canada House's wholly owned subsidiary Abba Medix Corp. will carry and distribute Pure Extracts' line of concentrate products. Canada House’s leadership team noted that it was impressed with the Pure…

TuesdayFeb 16, 2021 12:07 pm

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Enters Licensing Deal with Taste-T LLC

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, has announced its licensing deal with U.S. based Taste-T LLC. According to the update, Taste-T utilizes a proprietary manufacturing system to produce and package branded cannabis gummies and sells them in multiple U.S. states including Nevada, Massachusetts, Michigan and Oklahoma. Their famous products come in unique blister packaging and include Margarita Chill and Fireball Cinnamon. Pure Extracts has signed an agreement with exclusive rights for Canada and first rights to other countries around the world. Included…

WednesdayFeb 10, 2021 10:14 am

PsychedelicNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Studying Potential for Psychedelics in Treatment of Mental Health Conditions, Announces Addition of Mescaline to Subsidiary Medicine Programs

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, is involved in preclinical laboratory work designed to study a variety of psychotropic compounds, including psilocybin, mescaline, LSD, MDMA and DMT. The company also announced that its subsidiary, XPhyto Laboratories Inc., has added the production of mescaline to its psychedelic medicine programs. These psychedelic compounds show promising potential in treating mental conditions because they are known to modulate neurotransmitters such as serotonin and dopamine, which regulate cognition, perception and mood in individuals. Called a leader in innovating psychedelic drugs in a recent…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

PsychedelicNewsBreaks